AAPL316.22-3.75 (-1.17%) ▼|ABBV248.78-7.68 (-2.99%) ▼|ABT105.52-2.81 (-2.59%) ▼|ACN179.03-7.69 (-4.12%) ▼|ADBE257.26-9.25 (-3.47%) ▼|AMAT472.79+18.08 (+3.98%) ▲|AMD505.74+28.17 (+5.90%) ▲|AMGN393.17-44.06 (-10.08%) ▼|AMT175.73-0.12 (-0.07%) ▼|AMZN256.97-1.54 (-0.60%) ▼|AVGO368.56+10.67 (+2.98%) ▲|AXP326.10-0.06 (-0.02%) ▼|BA210.73-1.52 (-0.72%) ▼|BAC62.39-0.29 (-0.46%) ▼|BKNG180.30-12.99 (-6.72%) ▼|BLK1,095.37-21.19 (-1.90%) ▼|BMY64.69-2.13 (-3.19%) ▼|BNY162.85-1.99 (-1.21%) ▼|BRK-B505.83-0.20 (-0.04%) ▼|C136.74-0.98 (-0.71%) ▼|CAT822.48+8.54 (+1.05%) ▲|CL88.41-0.36 (-0.41%) ▼|CMCSA26.33-0.16 (-0.60%) ▼|COF213.96-5.64 (-2.57%) ▼|COP135.04+0.78 (+0.58%) ▲|COST910.18-5.56 (-0.61%) ▼|CRM249.12-10.11 (-3.90%) ▼|CSCO109.17-0.03 (-0.03%) ▼|CVS96.07-0.67 (-0.69%) ▼|CVX209.80+1.20 (+0.58%) ▲|DE680.73-12.80 (-1.85%) ▼|DHR205.23-2.43 (-1.17%) ▼|DIS105.06-0.25 (-0.24%) ▼|DUK121.24+1.02 (+0.85%) ▲|EMR152.15-0.67 (-0.44%) ▼|FDX314.13-8.39 (-2.60%) ▼|GD356.58-2.81 (-0.78%) ▼|GE334.91-2.21 (-0.66%) ▼|GEV971.31+29.36 (+3.12%) ▲|GILD146.64-4.36 (-2.88%) ▼|GM85.79-1.97 (-2.24%) ▼|GOOG335.38+0.07 (+0.02%) ▲|GOOGL338.36-0.10 (-0.03%) ▼|GS1,036.53-2.08 (-0.20%) ▼|HD313.70-7.35 (-2.29%) ▼|HON208.24-1.37 (-0.65%) ▼|IBM232.09-2.80 (-1.19%) ▼|INTC104.47+8.67 (+9.05%) ▲|INTU318.93-13.77 (-4.14%) ▼|ISRG350.16-16.54 (-4.51%) ▼|JNJ269.12-6.11 (-2.22%) ▼|JPM353.51-5.13 (-1.43%) ▼|KO88.36+0.29 (+0.33%) ▲|LIN468.38-9.19 (-1.92%) ▼|LLY1,123.91-25.45 (-2.21%) ▼|LMT536.15+10.87 (+2.07%) ▲|LOW200.80-3.65 (-1.79%) ▼|LRCX320.42+12.77 (+4.15%) ▲|MA570.89-8.32 (-1.44%) ▼|MCD255.81+0.12 (+0.05%) ▲|MDLZ61.63+0.35 (+0.57%) ▲|MDT92.39-1.78 (-1.89%) ▼|META613.48-3.29 (-0.53%) ▼|MMM167.52-1.04 (-0.62%) ▼|MO68.17-0.71 (-1.03%) ▼|MRK148.46-1.87 (-1.24%) ▼|MS216.24-1.48 (-0.68%) ▼|MSFT493.95-5.75 (-1.15%) ▼|MU1,000.26-16.33 (-1.61%) ▼|NEE83.83+0.40 (+0.48%) ▲|NFLX76.77-1.48 (-1.89%) ▼|NKE38.10-0.30 (-0.78%) ▼|NOW134.21-7.05 (-4.99%) ▼|NVDA225.73-4.63 (-2.01%) ▼|ORCL162.52+3.74 (+2.36%) ▲|PEP138.45+0.82 (+0.60%) ▲|PFE27.79-0.66 (-2.32%) ▼|PG145.58-0.86 (-0.59%) ▼|PLTR170.30-4.03 (-2.31%) ▼|PM184.73+2.20 (+1.21%) ▲|QCOM174.09+5.35 (+3.17%) ▲|RTX198.81-1.98 (-0.99%) ▼|SBUX102.01-2.46 (-2.35%) ▼|SCHW106.87-2.42 (-2.21%) ▼|SO88.99+0.88 (+1.00%) ▲|SPG211.88+2.44 (+1.17%) ▲|T25.60-0.08 (-0.31%) ▼|TMO603.02-10.76 (-1.75%) ▼|TMUS181.69+0.17 (+0.09%) ▲|TSLA368.16+14.08 (+3.98%) ▲|TXN258.92+0.48 (+0.19%) ▲|UBER73.13-2.63 (-3.47%) ▼|UNH400.84+3.70 (+0.93%) ▲|UNP288.45-1.17 (-0.40%) ▼|UPS100.48-1.81 (-1.77%) ▼|USB62.49-0.88 (-1.39%) ▼|V368.64-6.43 (-1.71%) ▼|VZ50.41+0.27 (+0.54%) ▲|WFC87.96-2.01 (-2.23%) ▼|WMT106.05-1.09 (-1.02%) ▼|XOM160.66+1.19 (+0.75%) ▲|AAPL316.22-3.75 (-1.17%) ▼|ABBV248.78-7.68 (-2.99%) ▼|ABT105.52-2.81 (-2.59%) ▼|ACN179.03-7.69 (-4.12%) ▼|ADBE257.26-9.25 (-3.47%) ▼|AMAT472.79+18.08 (+3.98%) ▲|AMD505.74+28.17 (+5.90%) ▲|AMGN393.17-44.06 (-10.08%) ▼|AMT175.73-0.12 (-0.07%) ▼|AMZN256.97-1.54 (-0.60%) ▼|AVGO368.56+10.67 (+2.98%) ▲|AXP326.10-0.06 (-0.02%) ▼|BA210.73-1.52 (-0.72%) ▼|BAC62.39-0.29 (-0.46%) ▼|BKNG180.30-12.99 (-6.72%) ▼|BLK1,095.37-21.19 (-1.90%) ▼|BMY64.69-2.13 (-3.19%) ▼|BNY162.85-1.99 (-1.21%) ▼|BRK-B505.83-0.20 (-0.04%) ▼|C136.74-0.98 (-0.71%) ▼|CAT822.48+8.54 (+1.05%) ▲|CL88.41-0.36 (-0.41%) ▼|CMCSA26.33-0.16 (-0.60%) ▼|COF213.96-5.64 (-2.57%) ▼|COP135.04+0.78 (+0.58%) ▲|COST910.18-5.56 (-0.61%) ▼|CRM249.12-10.11 (-3.90%) ▼|CSCO109.17-0.03 (-0.03%) ▼|CVS96.07-0.67 (-0.69%) ▼|CVX209.80+1.20 (+0.58%) ▲|DE680.73-12.80 (-1.85%) ▼|DHR205.23-2.43 (-1.17%) ▼|DIS105.06-0.25 (-0.24%) ▼|DUK121.24+1.02 (+0.85%) ▲|EMR152.15-0.67 (-0.44%) ▼|FDX314.13-8.39 (-2.60%) ▼|GD356.58-2.81 (-0.78%) ▼|GE334.91-2.21 (-0.66%) ▼|GEV971.31+29.36 (+3.12%) ▲|GILD146.64-4.36 (-2.88%) ▼|GM85.79-1.97 (-2.24%) ▼|GOOG335.38+0.07 (+0.02%) ▲|GOOGL338.36-0.10 (-0.03%) ▼|GS1,036.53-2.08 (-0.20%) ▼|HD313.70-7.35 (-2.29%) ▼|HON208.24-1.37 (-0.65%) ▼|IBM232.09-2.80 (-1.19%) ▼|INTC104.47+8.67 (+9.05%) ▲|INTU318.93-13.77 (-4.14%) ▼|ISRG350.16-16.54 (-4.51%) ▼|JNJ269.12-6.11 (-2.22%) ▼|JPM353.51-5.13 (-1.43%) ▼|KO88.36+0.29 (+0.33%) ▲|LIN468.38-9.19 (-1.92%) ▼|LLY1,123.91-25.45 (-2.21%) ▼|LMT536.15+10.87 (+2.07%) ▲|LOW200.80-3.65 (-1.79%) ▼|LRCX320.42+12.77 (+4.15%) ▲|MA570.89-8.32 (-1.44%) ▼|MCD255.81+0.12 (+0.05%) ▲|MDLZ61.63+0.35 (+0.57%) ▲|MDT92.39-1.78 (-1.89%) ▼|META613.48-3.29 (-0.53%) ▼|MMM167.52-1.04 (-0.62%) ▼|MO68.17-0.71 (-1.03%) ▼|MRK148.46-1.87 (-1.24%) ▼|MS216.24-1.48 (-0.68%) ▼|MSFT493.95-5.75 (-1.15%) ▼|MU1,000.26-16.33 (-1.61%) ▼|NEE83.83+0.40 (+0.48%) ▲|NFLX76.77-1.48 (-1.89%) ▼|NKE38.10-0.30 (-0.78%) ▼|NOW134.21-7.05 (-4.99%) ▼|NVDA225.73-4.63 (-2.01%) ▼|ORCL162.52+3.74 (+2.36%) ▲|PEP138.45+0.82 (+0.60%) ▲|PFE27.79-0.66 (-2.32%) ▼|PG145.58-0.86 (-0.59%) ▼|PLTR170.30-4.03 (-2.31%) ▼|PM184.73+2.20 (+1.21%) ▲|QCOM174.09+5.35 (+3.17%) ▲|RTX198.81-1.98 (-0.99%) ▼|SBUX102.01-2.46 (-2.35%) ▼|SCHW106.87-2.42 (-2.21%) ▼|SO88.99+0.88 (+1.00%) ▲|SPG211.88+2.44 (+1.17%) ▲|T25.60-0.08 (-0.31%) ▼|TMO603.02-10.76 (-1.75%) ▼|TMUS181.69+0.17 (+0.09%) ▲|TSLA368.16+14.08 (+3.98%) ▲|TXN258.92+0.48 (+0.19%) ▲|UBER73.13-2.63 (-3.47%) ▼|UNH400.84+3.70 (+0.93%) ▲|UNP288.45-1.17 (-0.40%) ▼|UPS100.48-1.81 (-1.77%) ▼|USB62.49-0.88 (-1.39%) ▼|V368.64-6.43 (-1.71%) ▼|VZ50.41+0.27 (+0.54%) ▲|WFC87.96-2.01 (-2.23%) ▼|WMT106.05-1.09 (-1.02%) ▼|XOM160.66+1.19 (+0.75%) ▲|
20.7 C
New York
Wednesday, September 9, 2026

Tag: plasma

newssourceFORcompanyinformationcontent1releasesmarket

Spine Degenerative Disk Disease Treatment Market to Reach USD 39,589.9 Billion by 2032, Growing at a CAGR of 4.39%: Credence Research

PUNE, India, July 9, 2025 /PRNewswire/ -- According to Credence Research, the global Spine Degenerative Disk Disease Treatment Market was valued at USD 22,272.2...

Global Energy Prize awarded to three scientists from China, USA and Russia

MONTEVIDEO, Uruguay, July 9, 2025 /PRNewswire/ -- The Global Energy Prize International Award Committee has named the laureates of the 2025 edition of the...

Global Energy Prize awarded to three scientists from China, USA and Russia

MONTEVIDEO, Uruguay, July 9, 2025 /PRNewswire/ -- The Global Energy Prize International Award Committee has named the laureates of the 2025 edition of the...

Emergent BioSolutions Secures $51.9 Million Contract Modification Award for CNJ-016® [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV) as part of U.S. Biodefense Preparedness Efforts

GAITHERSBURG, Md., July 08, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced a contract modification has been secured to deliver CNJ-016® [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV) to the Administration for Strategic Preparedness and Response (ASPR), part of the U. S. Department of Health and Human Services (HHS), for smallpox preparedness. ASPR exercised an option from its existing 10-year contract (75A50119C00037) for additional doses of VIGIV, a treatment for complications due to smallpox vaccination.

Graphenix Development Inc. Awarded $100,000 SuperBoost Grant to Extend Cycle Life of Silicon Anode Lithium-Ion Batteries

Graphenix Development Inc., a Rochester-based battery materials firm, receives a $100,000 SuperBoost grant from the NSF Energy Storage Engine.

IsoEnergy and Purepoint Confirm Uranium Discovery In Initial Drilling at the Dorado Joint Venture Project

TORONTO, July 8, 2025 /PRNewswire/ - IsoEnergy Ltd. (NYSE American: ISOU) (TSX: ISO) ("IsoEnergy") and Purepoint Uranium Group Inc. (TSXV: PTU) (OTC: PTUUF) ("Purepoint") are...

IsoEnergy and Purepoint Confirm Uranium Discovery In Initial Drilling at the Dorado Joint Venture Project

TORONTO, July 8, 2025 /CNW/ - IsoEnergy Ltd. (NYSE American: ISOU) (TSX: ISO) ("IsoEnergy") and Purepoint Uranium Group Inc. (TSXV: PTU) (OTC: PTUUF) ("Purepoint") are...

GR Silver Mining Reports Initial High-Grade Results from Plomosas Mine Sampling Program

VANCOUVER, BC, July 8, 2025 /CNW/ - GR Silver Mining Ltd. ("GR Silver Mining" or the "Company") (TSXV: GRSL) (OTCQB: GRSLF) (FRANKFURT: GPE) – is...

National Heart, Lung, and Blood Institute / National Institutes of Health Signs Clinical Trial Agreement with Vascarta Inc. to Perform Phase 1 Clinical Study...

SUMMIT, N.J., July 7, 2025 /PRNewswire/ -- Under the agreement, the National Heart, Lung, and Blood Institute / National Institutes of Health will perform...

GPRC5D-directed Therapies Market is Anticipated to Gain Momentum During the Forecast Period (2025-2034) Owing to Unmet Need in Multiple Myeloma | DelveInsight

The GPRC5D-directed therapies market is witnessing robust growth, driven by the high unmet need in relapsed/refractory multiple myeloma. Innovative modalities like CAR-T cells, bispecific...

GPRC5D-directed Therapies Market is Anticipated to Gain Momentum During the Forecast Period (2025-2034) Owing to Unmet Need in Multiple Myeloma | DelveInsight

The GPRC5D-directed therapies market is witnessing robust growth, driven by the high unmet need in relapsed/refractory multiple myeloma. Innovative modalities like CAR-T cells, bispecific...

BioAtla Presents Data from Ongoing Dose Escalation of BA3182, Dual-Conditionally Binding EpCAM x CD3 Bispecific T-cell Engager, in Patients with Treatment Refractory Metastatic Adenocarcinoma...

Adverse events were generally low-grade, transient, and readily manageable

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

RESEARCH TRIANGLE PARK, N.C., July 03, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted eight newly-hired employees restricted stock units (RSUs) covering an aggregate of 57,000 shares of BioCryst common stock. The RSUs were granted as of July 1, 2025, as inducements material to each employee entering into employment with BioCryst. The RSUs were granted in accordance with Nasdaq Listing Rule 5635(c)(4).

OXLUMO® (lumasiran injection) Now Reimbursed in Canada For the Treatment of Primary Hyperoxaluria Type 1 (PH1) in Pediatric and Adult Patients

OXLUMO has been shown to significantly reduce urinary oxalate, which drives the progression of PH1 Disease1 MISSISSAUGA, ON, July 2, 2025 /CNW/ - Alnylam Canada ULC...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPlasma

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers